Daewoong Pharma Tangible Net Worth Ratio
Daewoong Pharma tangible net worth ratio. Daewoong Pharma (069620) has a Tangible Net Worth Ratio of 63.0% as of September 2025. This metric is calculated by deducting intangible assets (₩371.20 Billion) from net assets (₩1.00 Trillion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Daewoong Pharma (069620) equity growth momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Daewoong Pharma (2007–2024)
Tangible net worth ratio of Daewoong Pharma from 2007 to 2024. This chart shows how Daewoong Pharma's Tangible Net Worth Ratio has changed across 16 annual periods from 2007 to 2024. As of September 2025, the ratio stands at 63.0%, reflecting net assets of ₩1.00 Trillion with intangible assets of ₩371.20 Billion KRW. Check asset allocation strategy of Daewoong Pharma to assess the company's strategic physical and investment asset allocation.
Daewoong Pharma Tangible Net Worth Ratio by Year (2007–2024)
Daewoong Pharma tangible net worth ratio by year from 2007 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Daewoong Pharma from 2007 to 2024, covering 16 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 069620 company net worth.
| Year | Tangible NW Ratio | Net Assets (KRW) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 69.2% | ₩926.98 Billion | ₩285.86 Billion | ₩1.98 Trillion | ▼ -5.1 pp |
| 2023 | 74.3% | ₩802.97 Billion | ₩206.67 Billion | ₩1.57 Trillion | ▲ +1.9 pp |
| 2022 | 72.3% | ₩741.22 Billion | ₩205.16 Billion | ₩1.56 Trillion | ▼ -4.3 pp |
| 2021 | 76.6% | ₩702.41 Billion | ₩164.32 Billion | ₩1.42 Trillion | ▼ -6.4 pp |
| 2020 | 83.0% | ₩695.25 Billion | ₩117.89 Billion | ₩1.37 Trillion | ▼ -0.6 pp |
| 2019 | 83.7% | ₩635.92 Billion | ₩103.84 Billion | ₩1.25 Trillion | ▼ -1.7 pp |
| 2018 | 85.4% | ₩607.81 Billion | ₩88.73 Billion | ₩1.21 Trillion | ▲ +3.3 pp |
| 2017 | 82.1% | ₩631.54 Billion | ₩113.13 Billion | ₩1.21 Trillion | ▼ -3.0 pp |
| 2016 | 85.1% | ₩604.55 Billion | ₩90.15 Billion | ₩1.14 Trillion | ▼ -5.8 pp |
| 2015 | 90.9% | ₩580.24 Billion | ₩52.65 Billion | ₩944.53 Billion | ▼ -2.2 pp |
| 2014 | 93.1% | ₩455.51 Billion | ₩31.41 Billion | ₩694.26 Billion | ▼ -0.6 pp |
| 2013 | 93.7% | ₩437.96 Billion | ₩27.76 Billion | ₩579.01 Billion | ▲ +1.3 pp |
| 2012 | 92.4% | ₩386.59 Billion | ₩29.52 Billion | ₩482.34 Billion | ▼ -1.1 pp |
| 2011 | 93.5% | ₩362.42 Billion | ₩23.73 Billion | ₩498.46 Billion | ▼ -3.2 pp |
| 2008 | 96.7% | ₩278.85 Billion | ₩9.30 Billion | ₩486.24 Billion | ▼ -2.2 pp |
| 2007 | 98.8% | ₩269.57 Billion | ₩3.17 Billion | ₩392.81 Billion | — |